Trial site
Kyorin University Hospital
- 29running trials
- 11closed trials
The trials here
What the 40 trials at this site are about, from their registry records.
- Conditions
- Ulcerative colitis12 trials
- Crohn's disease8 trials
- Alopecia areata6 trials
- High blood pressure4 trials
- Pulmonary arterial hypertension4 trials
- Coronary artery disease2 trials
- Stroke2 trials
- ANCA-associated vasculitis1 trial
- Atrial fibrillation1 trial
- Colorectal cancer1 trial
- Depression1 trial
- Familial hypercholesterolaemia1 trial
- and 2 more
- Phase
- Phase 322 trials
- Phase 28 trials
- Phase 2/33 trials
- Phase 1/22 trials
- Status
- Active, not recruiting14 trials
- Recruiting14 trials
- Completed10 trials
- Not yet recruiting1 trial
- Terminated1 trial
- Lead sponsor
- Janssen Research & Development, LLC9 trials
- Eli Lilly and Company8 trials
- Pfizer4 trials
- Takeda3 trials
- Actelion2 trials
- and 14 more
Running trials
Recruiting
Recruiting
Recruiting
Safety, Dosage, and Microbiome Engraftment Study of MGT-006 for Ulcerative Colitis (ROOT Study)
Recruiting
Recruiting
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
Recruiting
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
Recruiting
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Recruiting
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
Active, not recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata
Active, not recruiting
Active, not recruiting
Recruiting
Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting
Guideline Oriented Approach To Lipid Lowering In Asia-Pacific
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease
Active, not recruiting
A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Alopecia areata4 recruiting
- Crohn's disease3 recruiting
- Ulcerative colitis3 recruiting
- Coronary artery disease2 recruiting
- Depression1 recruiting
- Familial hypercholesterolaemia1 recruiting
- High blood pressure1 recruiting
- Pulmonary arterial hypertension1 recruiting
- Stroke1 recruiting
Closed trials
Completed
Completed
Satralizumab in the Treatment of Pulmonary Arterial Hypertension (SATISFY-JP Trial)
Completed
Completed
Terminated
Completed
A Study of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease
Completed
Completed
A Study of Baricitinib (LY3009104) in Adults With Severe or Very Severe Alopecia Areata
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 13 Nov 2026